Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 2929Neoplasms 2624Lung Neoplasms 1366Colorectal Neoplasms 1328Prostatic Neoplasms 1214Carcinoma, Non-Small-Cell Lung 1079Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Ovarian Neoplasms 586Colonic Neoplasms 533Uterine Cervical Neoplasms 497Head and Neck Neoplasms 495Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 404Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Urinary Bladder Neoplasms 386Leukemia, Myeloid, Acute 385Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 312Recurrence 298Disease 272

Interventions

Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Pancreatic Cancer Resectable × Clear all
NCT07157605 2025-09-05

SPLENDID

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting
94 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Kochi University

Completed
100 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT04736043 2021-02-03

Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid

Samsung Medical Center

Unknown
300 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡